Epstein Secrets

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

y Committee." The Times adds, "Justice Department Inspector General Michael Horowitz last year concluded the FBI made multiple errors when it asked the Foreign Intelligence Surveillance Court to approve a secret order EFTA00135716 to monitor Mr. Page in 2016 and 2017. The mistakes included multiple inaccuracies and omission of exculpat

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

y Committee." The Times adds, "Justice Department Inspector General Michael Horowitz last year concluded the FBI made multiple errors when it asked the Foreign Intelligence Surveillance Court to approve a secret order to monitor Mr. Page in 2016 and 2017. The mistakes included multiple inaccuracies and omission of exculpatory evidence. T

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

y Committee." The Times adds, "Justice Department Inspector General Michael Horowitz last year concluded the FBI made multiple errors when it asked the Foreign Intelligence Surveillance Court to approve a secret order to monitor Mr. Page in 2016 and 2017. The mistakes included multiple inaccuracies and omission of exculpatory evidence. T